Literature DB >> 2867466

Coombs' positive hemolytic anemia following sulfasalazine therapy in ulcerative colitis: case reports, review, and discussion of pathogenesis.

J I Mechanick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2867466

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN： 0027-2507


× No keyword cloud information.
  5 in total

1.  Immune complex haemolytic anaemia associated with sulfasalazine.

Authors:  V Teplitsky; I Virag; A Halabe
Journal:  BMJ       Date:  2000-04-22

2.  Anti-erythrocyte antibodies in ulcerative colitis: case report and discussion on the pathophysiology of anti-erythrocyte antibody.

Authors:  M Chiba; K Nakajima; H Arakawa; O Masamune; T Narisawa
Journal:  Gastroenterol Jpn       Date:  1988-10

3.  Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.

Authors:  M Pirmohamed; M D Coleman; F Hussain; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  Coombs-positive autoimmune hemolytic anemia in ulcerative colitis--a report of two cases.

Authors:  T Iwama; M Imajo; Y Mishima
Journal:  Jpn J Surg       Date:  1991-05

Review 5.  Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.

Authors:  Blas Y Betancourt; Ann Biehl; James D Katz; Ananta Subedi
Journal:  Rheum Dis Clin North Am       Date:  2018-06-12       Impact factor: 2.670
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.